Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00154778Phase 2Completed
Phase 2, open-label, single-arm trial of paclitaxel, tegafur + uracil and folinic acid in gastric cancer (GC), sponsored by National Taiwan University Hospital. Primary endpoint: Response Rate. Started Mar 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00154778.